Overview
Rheumatrex, also known as Methotrexate (drug name) and Trexall (alternative brand name), is a prescription medication approved by the Food and Drug Administration (FDA) in 1988 for treatment of rheumatoid arthritis. Rheumatrex can reduce joint pain and swelling as well as allow for the reduction in dosage of other drugs such as Prednisone.
Rheumatrex is an immunomodulator, or in other words, a drug that modulates the immune system. Rheumatrex is also referred to as a disease-modifying antirheumatic drug (DMARD) or a slow-acting antirheumatic drug (SAARD). It is an antimetabolite which blocks the synthesis of purine, a protein the body needs in order to produce lymphocytes. Lymphocytes are a type of white blood cell active in the immune system. Rheumatrex is believed to work by interfering with lymphocytes and preventing them from attacking the joints. ... read more
We never share your personal information with anyone.